Cost effectiveness analysis of screening for sight threatening diabetic eye disease

Por James, Marilyn, Turner, David A, Broadbent, Deborah M, Vora, Jiten, Harding, Simon P
Publicado em 2000

Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine

Por Eleuteri, Antonio, Fisher, Anthony C., Broadbent, Deborah M., García-Fiñana, Marta, Cheyne, Christopher P., Wang, Amu, Stratton, Irene M., Gabbay, Mark, Seddon, Daniel, Harding, Simon P.
Publicado no Diabetologia (2017)

Personalized risk‐based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules

Por García‐Fiñana, Marta, Hughes, David M., Cheyne, Christopher P., Broadbent, Deborah M., Wang, Amu, Komárek, Arnošt, Stratton, Irene M., Mobayen‐Rahni, Mehrdad, Alshukri, Ayesh, Vora, Jiten P., Harding, Simon P.
Publicado no Diabetes Obes Metab (2018)

Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT

Por Broadbent, Deborah M., Wang, Amu, Cheyne, Christopher P., James, Marilyn, Lathe, James, Stratton, Irene M., Roberts, John, Moitt, Tracy, Vora, Jiten P., Gabbay, Mark, García-Fiñana, Marta, Harding, Simon P.
Publicado no Diabetologia (2020)

Individualised screening for diabetic retinopathy: the ISDR study—rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based...

Por Broadbent, Deborah M, Sampson, Christopher J, Wang, Amu, Howard, Lola, Williams, Abigail E, Howlin, Susan U, Appelbe, Duncan, Moitt, Tracy, Cheyne, Christopher P, Rahni, Mehrdad Mobayen, Kelly, John, Collins, John, García-Fiñana, Marta, Stratton, Irene M, James, Marilyn, Harding, Simon P
Publicado no BMJ Open (2019)